Posts With Tag Immunology

Explore Protagonist Therapeutics' Q4 2024 financial report showcasing $434.4M revenue, $275.2M net income, and a strong 'Buy' recommendation for investors seeking growth in biotech.

Dive into AbbVie Inc.'s 2024 financial performance with $56.33B in revenues, key product insights, and future outlook amid litigation risks. Explore our hold recommendation.

Discover Evaxion Biotech A/S's latest Form 6-K report detailing debt conversion strategies and compliance efforts. Stay informed on AI-Immunology™ advancements and investor relations.